§ COMPARE REGULATORS

NMPA vs HSA: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of NMPA (China) vs HSA (Singapore).

NMPA

National Medical Products Administration (China)

China

China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing

CLASSES

Class I, II, III

PATHWAY

NMPA Registration (CMDE review)

KEY FUNCTIONS
  • CMDE technical review
  • MAH (Marketing Authorization Holder) system
  • In-country testing requirements
  • Clinical trial oversight
  • NMPA registration certificates

HSA

Health Sciences Authority (Singapore)

Singapore

Singapore's HSA regulates medical devices using a four-class risk-based system (A, B, C, D). HSA accepts conformity assessment from recognized bodies and is a founding member of IMDRF. Singapore serve

CLASSES

Class A, B, C, D

PATHWAY

HSA registration

KEY FUNCTIONS
  • Device registration (Class B-D)
  • Class A dealer license
  • GN-13 guidance compliance
  • Adverse event reporting
  • IMDRF participation

MedFlux monitors both NMPA and HSA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS